Weiss MJ, Ray K, Henthorn PS, Lamb B, Kadesch T, Harris H. ‘Structure of the human liver/bone/kidney alkaline phosphatase gene’. J Biol Chem, 263, 24, pp. 12002–10 PMID– 3165380, 1988.

Whyte MP. Hypophosphatasia: an overview for 2017. Bone. 2017;102:15–25. https://doi.org/10.1016/j.bone.2017.02.011.

Article  PubMed  CAS  Google Scholar 

Fallon MD, Teitelbaum SL, Weinstein RS, Goldfischer S, Brown DM, Whyte MP. Hypophosphatasia: clinicopathologic comparison of the infantile, childhood, and adult forms. Med (United States). 1984;63(1). https://doi.org/10.1097/00005792-198401000-00002.

Conti F. ‘Hypophosphatasia: clinical manifestation and burden of disease in adult patients’, Clinical Cases in Mineral and Bone Metabolism, vol. 14, no. 2, 2017, https://doi.org/10.11138/ccmbm/2017.14.1.230

Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA. ‘Clinical spectrum of hypophosphatasia diagnosed in adults’, Bone, vol. 54, no. 1, pp. 21–27, 2013, https://doi.org/10.1016/j.bone.2013.01.024

Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233–46. https://doi.org/10.1038/nrendo.2016.14.

Article  PubMed  CAS  Google Scholar 

Whyte MP. Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res. 2009;24(6):1132–4. https://doi.org/10.1359/jbmr.081253.

Article  PubMed  Google Scholar 

Whyte MP, Teitelbaum SL, Murphy WA, Bergfeld MA, Avioli LV. ‘Adult hypophosphatasia. Clinical, laboratory, and genetic investigation of a large kindred with review of the literature’, Medicine (Baltimore), vol. 58, no. 5, pp. 329–347 PMID: 481194, 1979.

McKenna MJ, Heffernan E, Hurson C, McKiernan FE. ‘Clinician approach to diagnosis of stress fractures including bisphosphonate-associated fractures’, QJM, vol. 107, no. 2, pp. 99–105, 2014, https://doi.org/10.1093/qjmed/hct192 PMID- 24106312.

Cook FJ, et al. Non-endemic skeletal fluorosis: causes and associated secondary hyperparathyroidism (case report and literature review). Bone. 2021;145:115839. https://doi.org/10.1016/j.bone.2021.115839.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Uday S, Högler W. Chapter 62 - Growth plate histology, bone histomorphometry, and radiologic features of nutritional rickets and osteomalacia. In: Hewison M, Bouillon R, Giovannucci E, Goltzman D, Meyer M, Welsh J, editors. Feldman and pike’s vitamin D (Fifth Edition). Academic; 2024. pp. 223–40. https://doi.org/10.1016/B978-0-323-91338-6.00012-4.

Hedge G, Thaker S, Botchu R, Fawcett R, Gupta H. Atraumatic fractures of the femur. Br J Radiol. Mar. 2021;94:20201457. https://doi.org/10.1259/bjr.20201457.

Rathbun JC. ‘Hypophosphatasia; a new developmental anomaly’, American Journal of Diseases of Children, vol. 75, no. 6, pp. 822–831, 1948, https://doi.org/10.1001/archpedi.1948.02030020840003 PMID- 18110134.

Bianchi ML. Hypophosphatasia: an overview of the disease and its treatment. Osteoporos Int. 2015;26:2743–57. https://doi.org/10.1007/s00198-015-3272-1.

Article  PubMed  CAS  Google Scholar 

Khan AA et al. ‘Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults’, 2024. https://doi.org/10.1007/s00198-023-06844-1

Mornet E, et al. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet. 2021;29(2):289–99. https://doi.org/10.1038/s41431-020-00732-6.

Article  PubMed  CAS  Google Scholar 

Fraser D. Hypophosphatasia. Am J Med. 1957;22(5):730–46. https://doi.org/10.1016/0002-9343(57)90124-9. PMID- 13410963.

Article  PubMed  CAS  Google Scholar 

Farman MR, et al. The global ALPL gene variant classification project: dedicated to Deciphering variants. Bone. 2024;178:116947. https://doi.org/10.1016/j.bone.2023.116947.

Article  PubMed  CAS  Google Scholar 

Fauvert D, et al. Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet. 2009;10:51. https://doi.org/10.1186/1471-2350-10-51.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Genest F, Seefried L. ‘Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all’, Osteoporosis International, vol. 29, no. 8, pp. 1815–1825, 2018, https://doi.org/10.1007/s00198-018-4552-3

Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B. A Molecular-Based Estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet. 2011;75(5):439–45. https://doi.org/10.1111/j.1469-1809.2011.00642.x.

Article  PubMed  Google Scholar 

Yu Y, Rong K, Yao D. The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase. Nat Commun. 2023;14:4048. https://doi.org/10.1038/s41467-023-39833-3.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hofmann C, Girschick H, Mornet E, Schneider D, Jakob F, Mentrup B. Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia. Eur J Hum Genet. 2014;22(10):1160–4. https://doi.org/10.1038/ejhg.2014.10. PMID: 24569605 PMCID: PMC4169536.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hames A, et al. Carriers of autosomal recessive conditions: are they really unaffected? J Med Genet. 2023;61(1):1–7. https://doi.org/10.1136/jmg-2023-109563. PMID- 37775265.

Article  PubMed  CAS  Google Scholar 

Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023;67(5):e000626. https://doi.org/10.20945/2359-3997000000626.

Article  PubMed  PubMed Central  Google Scholar 

Desborough R, et al. Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic. Bone. 2021;144. https://doi.org/10.1016/j.bone.2020.115795.

Tornero C, de Miguel E, Navarro-Compán V, Balsa A, Aguado P. ‘Prevalence of chondrocalcinosis and calcium pyrophosphate deposition disease in a cohort of adult patients with low alkaline phosphatase levels and a positive versus negative genetic ALPL study’, JBMR Plus, vol. 8, no. 11, p. ziae124, 2024, https://doi.org/10.1093/jbmrpl/ziae124 PMID: 39450343 PMCID: PMC11499678.

Seefried L et al. ‘Fracture Rate and Location in Adults with Hypophosphatasia with One Versus Multiple ALPL Variants: Data from the Global Hypophosphatasia Registry’, in Oral presentation at WCO-IOF-ESCEO, London, 2024.

Arboleya L, Braña I, Pardo E, Loredo M, Queiro R. Osteomalacia in adults: A practical insight for clinicians. J Clin Med. 2023;12:2714. https://doi.org/10.3390/jcm12072714. PMID: 37048797 PMCID: PMC10094844.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Steinbach HL, Noetzli M. ‘Roentgen appearance of the skeleton in osteomalacia and rickets’, American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine, vol. 91, pp. 955–972 PMID – 14158235, 1964.

Barvencik F, et al. Skeletal mineralization defects in adult hypophosphatasia - A clinical and histological analysis. Osteoporos Int. 2011;22(10). https://doi.org/10.1007/s00198-011-1528-y.

Sutton RA, Mumm S, Coburn SP, Ericson KL, Whyte MP. Atypical femoral fractures during bisphosphonate exposure in adult hypophosphatasia. J Bone Min Res. 2012;27(5):987–94. https://doi.org/10.1002/jbmr.1565.

Article  CAS  Google Scholar 

Shane E, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American society for bone and mineral research. J Bone Min Res. 2014;29(1):1–23. https://doi.org/10.1002/jbmr.1998.

Article  Google Scholar 

Coe JD, Murphy WA, Whyte MP. ‘Management of femoral fractures and pseudofractures in adult hypophosphatasia’, J Bone Joint Surg Am, vol. 68, no. 7, pp. 981–990, 1986, [Online]. Available: https://api.semanticscholar.org/CorpusID:46242610

Nguyen HH, van de Laarschot DM, Verkerk AJMH, Milat F, Zillikens MC, Ebeling PR. Genetic risk factors for atypical femoral fractures (AFFs): A systematic review. JBMR Plus. 2018;2(1):1–11. https://doi.org/10.1002/jbm4.10024.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Charoenngam N, et al. Atypical femoral fracture in hypophosphatasia: A systematic review. Int J Endocrinol. 2023;5544148. https://doi.org/10.1155/2023/5544148.

Golden RD, Rodriguez EK. ‘Management of subtrochanteric femur fractures with internal fixation and recombinant human bone morphogenetic protein-7 in a patient with osteopetrosis: a case report’, J Med Case Rep, vol. 4, no. 1, p. 142, Dec. 2010, https://doi.org/10.1186/1752-1947-4-142

Lawrence JE, Saeed D, Bartlett J, Carrothers AD. ‘Adult-onset hypophosphatasia diagnosed following bilateral atypical femoral fractures in a 55-year-old woman’, Clinical Cases in Mineral and Bone Metabolism, vol. 14, no. 3, pp. 347–353, 2017, https://doi.org/10.11138/ccmbm/2017.14.3.347

Moss KE, et al. Mobility and quality of life in adults with Paediatric-Onset hypophosphatasia treated with asfotase alfa: results from UK managed access agreement. Adv Ther. 2025;42(5):2429–44. https://doi.org/10.1007/s12325-025-03168-w. PMID: 40138164 PMCID: PMC12006239.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schalin-Jäntti C, Mornet E, Lamminen A, Välimäki MJ. ‘Parathyroid Hormone Treatment Improves Pain and Fracture Healing in Adult Hypophosphatasia’, J Clin Endocrinol Metab, vol. 95, no. 12, pp. 5174–5179, Dec. 2010, https://doi.org/10.1210/jc.2010-1168

Whyte MP, Mumm S, Deal C. ‘Adult Hypophosphatasia Treated with Teriparatide’, J Clin Endocrinol Metab, vol. 92, no. 4, pp. 1203–1208, Apr. 2007, https://doi.org/10.1210/jc.2006-1902

de Oliveira FA et al. Apr., ‘Preclinical evaluation of the efficacy and safety of adeno-associated virus 8-tissue-nonspecific alkaline phosphatase-D10 in Alpl-/- and AlplPrx1/Prx1 mouse models for the treatment of early and late-onset hypophosphatasia’, Journal of Bone and Mineral Research, vol. 40, no. 4, pp. 463–477, 2025, https://doi.org/10.1093/jbmr/zjaf005

Shore RM, Langman CB, Poznanski AK. Lumbar and radial bone mineral density in children and adolescents with X-linked hypophosphatemia: evaluation with dual X-ray absorptiometry. Skeletal Radiol. 2000;29(2):90–3.

Article  PubMed  CAS  Google Scholar 

Beck-Nielsen SS, Brixen K, Gram J, Mølgaard C. High bone mineral apparent density in children with X-linked hypophosphatemia. Osteoporos Int. 2013;24(8):2215–21.

Article  PubMed  CAS  Google Scholar 

S. et al. Dillon, ‘Abstracts of the ECTS 2024 Congress’, JBMR Plus, vol. 8, no. Supplement_1, pp. i1–i340, Apr. 2024, https://doi.org/10.1093/jbmrpl/ziae063

Genest F, Claußen L, Rak D, Seefried L. Bone mineral density and fracture risk in adult patients with hypophosphatasia. Osteoporos Int. 2021;32(2). https://doi.org/10.1007/s00198-020-05612-9.

Bhambri R, et al. Changes in bone mineral density following treatment of osteomalacia. J Clin Densitometry. 2006;9(1):120–7. https://doi.org/10.1016/j.jocd.2005.11.001.

Article  Google Scholar 

Reid IR, Murphy WA, Hardy DC, Teitelbaum SL, Bergfeld MA, Whyte MP. X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry. Am J Med. Jan. 1991;90(1):63–9.